Примери за използване на Safety profiles на Английски и техните преводи на Български
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Computer
Showed similar safety profiles between treatments.
Safety profiles were similar to those previously reported.
The observed effects and the safety profiles were comparable between all age groups.
The safety profiles were comparable for the two different formulations after a single dose.
There were no differences in the safety profiles for paediatric patients treated for SCN.
Хората също превеждат
The safety profiles of the administered vaccines were comparable(see section 4.8).
There were no differences in the safety profiles for paediatric patients treated for SCN.
The safety profiles in the different paediatric subsets of age appear similar.
There were no differences in the safety profiles for paediatric patients treated for SCN.
The safety profiles of the recommended dose and half of the recommended dose were comparable.
The observed improvements in HbA1c and the safety profiles were comparable between all age groups.
The safety profiles of the two medicines were also considered similar, based on laboratory testing.
Clinical studies demonstrated that the immune responses and the safety profiles of the administered vaccines were unaffected.
The short-term safety profiles in the different paediatric subsets were also similar(see section 5.1).
Post hoc subgroup analyses of EAGER data compared the safety profiles of TIP and TIS in children, adolescents, and adults.
The short-term safety profiles in the different paediatric subsets were also similar(see section 5.1).
The adverse reactions shown in the table below(see Table 1) are listed by system organ class andare based on the safety profiles of empagliflozin and linagliptin monotherapy.
The pemetrexed maintenance safety profiles from the two studies JMEN and PARAMOUNT were similar.
The safety profiles of IXIARO and the other studied vaccines were not compromised when administered concomitantly.
Alternative antihypertensive treatments with more established safety profiles during breastfeeding are preferable, especially while nursing a newborn or preterm baby.
The safety profiles of entecavir and lamivudine, including laboratory test abnormalities, were comparable in these studies.
The pharmacokinetic and safety profiles did not identify any safety concerns.
Safety profiles of cannabinoids seem acceptable, although a slow prolonged period of titration improves tolerability.
Alternative treatments with better established safety profiles during breast-feeding are preferable, especially while nursing a newborn or preterm infant.
The safety profiles of Xeloda monotherapy for the metastatic breast cancer, metastatic colorectal cancer and adjuvant colon cancer populations are comparable.
No meaningful differences in the safety profiles were observed between the elderly subject population and subjects 18 to 65 years of age.
Overall, the safety profiles in the breast cancer and soft tissue sarcoma patient populations were similar.
Alternative treatments with better established safety profiles during breast-feeding are preferable, especially while nursing a newborn or preterm infant.
The short-term safety profiles in the different paediatric subsets were also similar(see section 5.1).
Results of clinical studies indicate similar safety profiles in adults and paediatric population, including the nature, frequency, seriousness and reversibility of adverse reactions.